News

Using GE Healthcare’s single-use WAVE Bioreactor and ReadyToProcess crossflow filtration system, the team developed a new process for the production, clarification and concentration of cytomegalovirus-like particles. Results from

The SwRI technologies employ a controlled and continuous atomizing technology that Flexion believes may facilitate efficient scale-up of Phase III clinical trial material and commercial supply. The company

Once issued, this patent will provide protection in Japan until 2029. The claims under the patent cover composition of matter and methods of use for combining Advaxis’s proprietary

The data were presented in the late-breaking session at the 2014 World Transplant Conference (WTC) in San Francisco, CA by Dr. V. Ram Peddi, Director of Kidney Transplant

"ALPHAEON’s acquisition of PRN brings together world renowned ophthalmologists and a premier physician recommended line of nutriceutical products that benefit patients," said CEO Robert E. Grant. "Over the

The current Upsher-Smith Galaxy Portfolio includes seven frequently prescribed AEDs which represent more than one out of every three prescriptions written for seizure disorders. The launch of the

Penn Pharmaceuticals is a UK based global provider of specialist pharmaceutical services providing selected Contract Development and Manufacturing Organisation (CDMO) services to a global customer base to support

Zydelig was approved by the U.S. Food and Drug Administration on July 23, 2014 for the treatment of three B-cell blood cancers. "We are pleased to partner with

Apart from Norway, ILUVIEN is now approved for marketing in Austria, France, Germany, Italy, Portugal, Spain and the UK, and is commercially available in the UK and Germany.